progression free survival | ||||
Study | topotecan | PLD | RR | P value |
progression free survival | ||||
Gordon 2004a | 16.1 | 17.0 | not given | 0.095 |
progression free survival(platium‐sensitive) | ||||
Gordon 2004a | 23.3 | 28.9 | not given | 0.037 |
progression free survival(platium‐resistant) | ||||
Gordon 2004a | 13.6 | 9.1 | not given | 0.733 |